TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Bone Metastasis Market, by Type
6.1 Introduction
6.2 Osteolytic Bone Metastasis
Market Estimates & Forecast, 2020โ2027
6.3 Osteoblastic Bone Metastasis
Market Estimates & Forecast, 2020โ2027
6.4 Mixed Bone Metastasis
Market Estimates & Forecast, 2020โ2027
6.5 Others
Chapter 7. Global Bone Metastasis Market, by Diagnosis
7.1 Introduction
7.2 Biopsy
Market Estimates & Forecast, 2020โ2027
7.3 Blood Test
Market Estimates & Forecast, 2020โ2027
7.4 Imaging
Market Estimates & Forecast, 2020โ2027
7.4.1 X-ray
7.4.2 Bone Scintigraphy
7.4.3 Computerized Tomography
7.4.4 Magnetic Resonance Imaging
7.4.5 Positron Emission Tomography
7.4.6 Others
7.5 Others
Chapter 8. Global Bone Metastasis Market, by Treatment
8.1 Introduction
8.2 Medical Therapies
Market Estimates & Forecast, 2020โ2027
8.2.1 Chemotherapy
8.2.2 Targeted therapy
8.2.3 Hormone therapy
8.2.4 Ablation Therapy
Market Estimates & Forecast, 2020โ2027
8.2.4.1 Radiofrequency Ablation
8.2.4.2 Cryoablation
8.2.4.3 Others
8.2.5 Others
8.3 Surgery
Market Estimates & Forecast, 2020โ2027
8.3.1 Vertebroplasty
8.3.2 Kyphoplasty
8.4 Medication
Market Estimates & Forecast, 2020โ2027
8.4.1 Pain Medications
Market Estimates & Forecast, 2020โ2027
8.4.1.1 Ibuprofen
8.4.1.2 Morphine
8.4.1.3 Others
8.4.2 Bone-Building Medications
Market Estimates & Forecast, 2020โ2027
8.4.2.1 Corticosteroids
8.4.2.2 Bisphosphonates
Market Estimates & Forecast, 2020โ2027
8.4.2.2.1 Teriparatide
8.4.2.2.2 Pamidronate
8.4.2.2.3 Medronate
8.5 Others
Chapter 9. Global Bone Metastasis Market, by End-User
9.1 Introduction
9.2 Hospital & Clinics
Market Estimates & Forecast, 2020โ2027
9.3 Diagnostic Centers
Market Estimates & Forecast, 2020โ2027
9.4 Pharmacies
Market Estimates & Forecast, 2020โ2027
9.5 Ambulatory Surgical Centers
Market Estimates & Forecast, 2020โ2027
9.6 Others
Chapter 10. Global Bone Metastasis Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K.
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 Bayer AG
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Merck & Co., Inc.
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Pfizer Inc.
12.4.1 Company Overview
12.4.2 Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Novartis AG
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Pharmalucence Inc.
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Koninklijke Philips N.V.
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 GENERAL ELECTRIC
12.8.1 Overview
12.8.2 Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Siemens AG
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 TOSHIBA CORPORATION
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Bone Metastasis Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Bone Metastasis Industry Synopsis, 2020โ2027
Table 2 Global Bone Metastasis Market Estimates & Forecast, 2020โ2027, (USD Million)
Table 3 Global Bone Metastasis Market, by Region, 2020โ2027, (USD Million)
Table 4 Global Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 5 Global Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 6 Global Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 7 Global Bone Metastasis Market, by End-User, 2020โ2027, (USD Million
Table 8 North America Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 9 North America Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 10 North America Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 11 North America Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 12 U.S. Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 13 U.S. Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 14 U.S. Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 15 U.S. Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 16 Canada Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 17 Canada Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 18 Canada Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 19 Canada Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 20 South America Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 21 South America Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 22 South America Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 23 South America Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 24 Europe Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 25 Europe Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 26 Europe Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 27 Europe Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 28 Western Europe Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 29 Western Europe Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 30 Western Europe Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 31 Western Europe Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 32 Eastern Europe Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 33 Eastern Europe Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 34 Eastern Europe Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 35 Eastern Europe Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 36 Asia Pacific Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 37 Asia Pacific Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 38 Asia Pacific Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 39 Asia Pacific Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
Table 40 The Middle East & Africa Bone Metastasis Market, by Type, 2020โ2027, (USD Million)
Table 41 The Middle East & Africa Bone Metastasis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 42 The Middle East & Africa Bone Metastasis Market, by Treatment, 2020โ2027, (USD Million)
Table 43 The Middle East & Africa Bone Metastasis Market, by End-User, 2020โ2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Bone Metastasis Market
Figure 3 Market Dynamics for Global Bone Metastasis Market
Figure 4 Global Bone Metastasis Market Share, by Type 2020
Figure 5 Global Bone Metastasis Market Share, by Diagnosis 2020
Figure 6 Global Bone Metastasis Market Share, by Treatment, 2020
Figure 7 Global Bone Metastasis Market Share, by End-User, 2020
Figure 8 Global Bone Metastasis Market Share, by Region, 2020
Figure 9 North America Bone Metastasis Market Share, by Country, 2020
Figure 10 Europe Bone Metastasis Market Share, by Country, 2020
Figure 11 Asia Pacific Bone Metastasis Market Share, by Country, 2020
Figure 12 The Middle East & Africa Bone Metastasis Market Share, by Country, 2020
Figure 13 Global Bone Metastasis Market: Company Share Analysis, 2020 (%)
Figure 14 F. Hoffmann-La Roche Ltd: Key Financials
Figure 15 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 16 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 17 Bayer AG: Key Financials
Figure 18 Bayer AG: Segmental Revenue
Figure 19 Bayer AG: Geographical Revenue
Figure 20 Merck & Co., Inc.: Key Financials
Figure 21 Merck & Co., Inc.: Segmental Revenue
Figure 22 Merck & Co., Inc.: Geographical Revenue
Figure 23 Pfizer Inc.: Key Financials
Figure 24 Pfizer Inc.: Segmental Revenue
Figure 25 Pfizer Inc.: Geographical Revenue
Figure 26 Novartis AG: Key Financials
Figure 27 Novartis AG: Segmental Revenue
Figure 28 Novartis AG: Geographical Revenue
Figure 29 Pharmalucence Inc.: Key Financials
Figure 30 Pharmalucence Inc.: Segmental Revenue
Figure 31 Pharmalucence Inc.: Geographical Revenue
Figure 32 Koninklijke Philips N.V.: Key Financials
Figure 33 Koninklijke Philips N.V.: Segmental Revenue
Figure 34 Koninklijke Philips N.V.: Geographical Revenue
Figure 35 GENERAL ELECTRIC: Key Financials
Figure 36 GENERAL ELECTRIC: Segmental Revenue
Figure 37 GENERAL ELECTRIC: Geographical Revenue
Figure 38 Siemens AG: Key Financials
Figure 39 Siemens AG: Segmental Revenue
Figure 40 Siemens AG: Geographical Revenue
Figure 41 TOSHIBA CORPORATION: Key Financials
Figure 42 TOSHIBA CORPORATION: Segmental Revenue
Figure 43 TOSHIBA CORPORATION: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
